Drug Approval | June 08, 2022
Lupin receives tentative approval from FDA for Ivacaftor tablets
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
AstraZeneca also played a critical role in the global response to COVID-19.
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
Subscribe To Our Newsletter & Stay Updated
